The stock of DENTSPLY Sirona Inc (NASDAQ:XRAY) last traded at $27.89, down -1.10% from the previous session.
XRAY stock price is now -12.02% away from the 50-day moving average and -17.04% away from the 200-day moving average. The market capitalization of the company currently stands at $5.79B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
#####
With the price target of $42, Leerink Partners recently initiated with Outperform rating for DENTSPLY Sirona Inc (NASDAQ: XRAY). On November 16, 2023, Needham recently initiated its ‘Buy’ rating on the stock quoting a target price of $35, while ‘William Blair’ rates the stock as ‘Outperform’
In other news, LUCIER GREGORY T, Director bought 10,000 shares of the company’s stock on Nov 22 ’23. The stock was bought for $314,400 at an average price of $31.44. Upon completion of the transaction, the Director now directly owns 43,121 shares in the company, valued at $1.2 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 20 ’23, Executive VP & CFO Coleman Glenn bought 10,000 shares of the business’s stock. A total of $297,000 was incurred on buying the stock at an average price of $29.70. This leaves the insider owning 73,566 shares of the company worth $2.05 million. A total of 0.98% of the company’s stock is owned by insiders.
During the past 12 months, DENTSPLY Sirona Inc has had a low of $26.27 and a high of $41.65. As of last week, the company has a debt-to-equity ratio of 0.68, a current ratio of 1.43, and a quick ratio of 0.97.
The net profit margin was -2.41% and return on equity was -2.75% for XRAY. The company reported revenue of $953.0 million for the quarter, compared to $978.0 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -2.56 percent.
#####
#####